Clinical Study of Imported Drugs in China

The company focuses on the efficient development of clinical trial study. Focus on the excellent therapeutic drugs can be quickly marketed in China. The expert team has many years of ICH country drug marketing management experience, involving Phase I-III clinical study, BE and post approval clinical study.

Pre /multiple pre BE study;

China /International BE study;

Phase II, III clinical study;

Real world study;

Phase IV post approval study;

Third party audit services;

Application for approval of human genetic resources;

Data management;

Clinical report review, etc.